Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed T-Cell Acute Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06064903
What this trial is testing

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Bambino Gesù Hospital and Research Institute 26
Testing effectiveness (Phase 2)Looking for participantsNCT05658640
What this trial is testing

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Very early researchUnknownNCT04028440
What this trial is testing

ΓδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic Leukemia+1 more
Institute of Hematology & Blood Diseases Hospital, China 6
Not applicableLooking for participantsNCT06961669
What this trial is testing

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Who this might be right for
Lymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital 18
Early research (Phase 1)Ended earlyNCT04049383
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionAcute Lymphoblastic Leukemia Recurrent+3 more
Medical College of Wisconsin 5
Testing effectiveness (Phase 2)Ended earlyNCT00742495
What this trial is testing

Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

Who this might be right for
Relapsed or Refractory T-cell Acute Lymphoblastic LeukaemiaB-cell Precursor Acute Lymphoblastic LeukaemiaT-cell Non-Hodgkin's Lymphoma
Mundipharma Research Limited 2
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Looking for participantsNCT05887167
What this trial is testing

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Who this might be right for
Hematologic MalignancyLarge B-cell LymphomaAcute Lymphoblastic Leukemia+3 more
Joshua Sasine, MD, PhD 20
Testing effectiveness (Phase 2)UnknownNCT04534634
What this trial is testing

Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 60
Early research (Phase 1)Ended earlyNCT00101231
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 88
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Early research (Phase 1)UnknownNCT04594135
What this trial is testing

Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin Lymphoma
iCell Gene Therapeutics 20
Testing effectiveness (Phase 2)WithdrawnNCT05320380
What this trial is testing

The Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT01943682
What this trial is testing

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more
Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)UnknownNCT03366350
What this trial is testing

Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 50
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT04185220
What this trial is testing

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Adult T-Cell Lymphoma/LeukemiaSezary SyndromeMycosis Fungoides
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Next Page
26